Índice Bovespa

US Dollar vs BRL

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
BioPlus Acquisition Corporation (BIOSU)
BioPlus Acquisition Corporation (BIOSU) Notícias

BIOSU

BioPlus Acquisition (BIOSU)

BioPlus Acquisition Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:BIOSU

1

Data	Hora	Fonte	Título	Código	Companhia
16/10/2023	17:15	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:BIOSU	BioPlus Acquisition Corporation
04/10/2023	08:39	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:BIOSU	BioPlus Acquisition Corporation
04/10/2023	08:32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOSU	BioPlus Acquisition Corporation
04/10/2023	08:30	GlobeNewswire Inc.	BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate	NASDAQ:BIOSU	BioPlus Acquisition Corporation
15/09/2023	17:00	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:BIOSU	BioPlus Acquisition Corporation
14/08/2023	17:11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BIOSU	BioPlus Acquisition Corporation
14/06/2023	07:09	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
14/06/2023	07:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
15/05/2023	17:29	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
15/05/2023	07:38	Edgar (US Regulatory)	Securities Registration: Business Combination (s-4)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
12/05/2023	17:17	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
27/04/2023	17:35	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
14/02/2023	17:39	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
02/02/2023	12:10	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
11/03/2022	18:05	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
06/12/2021	10:00	GlobeNewswire Inc.	BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering	NASDAQ:BIOSU	BioPlus Acquisition Corporation

Apresentando as notícias mais relevantes sobre:NASDAQ:BIOSU

1

CM Hospitalar ON

Índice Bovespa

$Logo da Infracommerce Caxaas ON (IFCM3).$

Infracommerce Caxaas ON

MAGAZINE LUIZA ON

HBR Realty Empreendiment... ON

TIME FOR FUN ON

PÃO DE AÇUCAR ON

Sequoia Logistica e Tran... ON

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições